{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:22:45Z","timestamp":1782433365206,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Lafora disease is a rare genetic disorder involving glycogen metabolism disorder. It is inherited by autosomal recessive pattern presenting as a progressive myoclonus epilepsy and neurologic deterioration beginning in adolescence. It is characterized by Lafora bodies in tissues such as brain, skin, muscle, and liver.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We report a rare case of Lafora disease in a 16-year-old Albanian girl who presented at a tertiary health care center with generalized tonic\u2013clonic seizures, eyelid twitches, hallucinations, headache, and cognitive dysfunction. She was initially treated for generalized epilepsy and received an antiepileptic drug. However, owing to resistance of seizures to this antiepileptic drug, a second drug was introduced. However, seizures continued despite compliance with therapy, and general neurological status began to deteriorate. The child began to have hallucinations and decline of cognitive function. She developed dysarthria and unsteady gait. When admitted to the hospital, blood tests and imaging examinations were planned. The blood tests were unremarkable. There was no relevant family history and no consanguinity. Electroencephalography showed multifocal discharges in both hemispheres, and brain magnetic resonance imaging revealed no abnormality. Axillary skin biopsy revealed inclusion bodies in apocrine glands. Consequently, the child was referred to an advanced center for genetic testing, which also confirmed diagnosis of Lafora disease with a positive mutation on<jats:italic>NHLRC1<\/jats:italic>gene.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>\u00a0Even though rare as a condition, Lafora disease should be considered on differential diagnosis in progressive and drug-refractory epilepsy in adolescents, especially when followed by cognitive decline.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13256-022-03537-x","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T11:02:41Z","timestamp":1664794961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Lafora disease: a case report"],"prefix":"10.1186","volume":"16","author":[{"given":"Naim","family":"Zeka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonore","family":"Zogaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdurrahim","family":"Gerguri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramush","family":"Bejiqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragip","family":"Ratkoceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlinda","family":"Maloku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aferdita","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Labinot","family":"Shahini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeton","family":"Maxharaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"issue":"1","key":"3537_CR1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1684\/epd.2012.0489","volume":"14","author":"S Gokdemir","year":"2021","unstructured":"Gokdemir S, \u00c7a\u011flayan H, K\u0131z\u0131ltan M, Karaa\u011fa\u00e7 N, Leblebici C, Yeni N. Presentation of an unusual patient with Lafora disease. Epilectic Disord. 2021;14(1):94\u20138.","journal-title":"Epilectic Disord"},{"issue":"1","key":"3537_CR2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.6793.PMID:32140352;PMCID:PMC7046017","volume":"12","author":"Y Al Mufargi","year":"2020","unstructured":"Al Mufargi Y, Qureshi A, Al AA. Lafora disease: report of a rare entity. Cureus. 2020;12(1): e6793. https:\/\/doi.org\/10.7759\/cureus.6793.PMID:32140352;PMCID:PMC7046017.","journal-title":"Cureus."},{"issue":"10","key":"3537_CR3","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41582-018-0057-0.PMID:30143794;PMCID:PMC6317072","volume":"14","author":"F Nitschke","year":"2018","unstructured":"Nitschke F, Ahonen SJ, Nitschke S, Mitra S, Minassian BA. Lafora disease\u2014from pathogenesis to treatment strategies. Nat Rev Neurol. 2018;14(10):606\u201317. https:\/\/doi.org\/10.1038\/s41582-018-0057-0.PMID:30143794;PMCID:PMC6317072.","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"3537_CR4","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00109-011-0758-y","volume":"89","author":"P Couarch","year":"2011","unstructured":"Couarch P, Vernia S, Gourfinkel-An I, Lesca G, Gataullina S, Fedirko E, Trouillard O, Depienne C, Dulac O, Steschenko D, Leguern E, Sanz P, Baulac S. Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism. J Mol Med. 2011;89(9):915\u201325. https:\/\/doi.org\/10.1007\/s00109-011-0758-y.","journal-title":"J Mol Med"},{"issue":"33","key":"3537_CR5","doi-asserted-by":"publisher","first-page":"25372","DOI":"10.1074\/jbc.M110.148668","volume":"285","author":"AA DePaoli-Roach","year":"2010","unstructured":"DePaoli-Roach AA, Tagliabracci VS, Segvich DM, Meyer CM, Irimia JM, Roach PJ. Genetic depletion of the malin E3 ubiquitin ligase in mice leads to Lafora bodies and the accumulation of insoluble laforin. J Biol Chem. 2010;285(33):25372\u201381. https:\/\/doi.org\/10.1074\/jbc.M110.148668.","journal-title":"J Biol Chem."},{"key":"3537_CR6","first-page":"34","volume":"18","author":"\u00d6 Bekta\u015f","year":"2013","unstructured":"Bekta\u015f \u00d6, Y\u0131lmaz A, Okcu AH, Teber S, Aksoy E, Deda G. A type of progressive myoclonic epilepsy, Lafora disease: a case report. East J Med. 2013;18:34\u20136.","journal-title":"East J Med"},{"issue":"S2","key":"3537_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1684\/epd.2016.0842.PMID:27702709;PMCID:PMC5777303","volume":"18","author":"J Turnbull","year":"2016","unstructured":"Turnbull J, Tiberia E, Striano P, Genton P, Carpenter S, Ackerley CA, Minassian BA. Lafora disease. Epileptic Disord. 2016;18(S2):38\u201362. https:\/\/doi.org\/10.1684\/epd.2016.0842.PMID:27702709;PMCID:PMC5777303.","journal-title":"Epileptic Disord"},{"issue":"2","key":"3537_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.7241\/ourd.20162.55","volume":"7","author":"M Yahia","year":"2016","unstructured":"Yahia M, Laabidi B, M\u2019sakni I, Bougrine F, Bouziani A. Lafora disease: a case report. Our Dermatol Online. 2016;7(2):201\u20133.","journal-title":"Our Dermatol Online."},{"issue":"6","key":"3537_CR9","doi-asserted-by":"publisher","first-page":"672","DOI":"10.4103\/0378-6323.45129","volume":"74","author":"PR Malur","year":"2008","unstructured":"Malur PR, Davanageri RS, Bannur HB, Suranagi VV. Lafora\u2019s disease diagnosed on axillary skin biopsy in 3 patients. Indian J Dermatol Venereol Leprol. 2008;74(6):672\u20133. https:\/\/doi.org\/10.4103\/0378-6323.45129.","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"3537_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5350\/DAJPN2016290210","volume":"29","author":"OD Esra","year":"2016","unstructured":"Esra OD. Lafora disease presenting with acute anxiety: a case report. Dusunen Adam J Psychiatr Neurol Sci. 2016;29:173\u20136. https:\/\/doi.org\/10.5350\/DAJPN2016290210.","journal-title":"Dusunen Adam J Psychiatr Neurol Sci"},{"issue":"2","key":"3537_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ebcr.2014.09.003.PMID:25667898;PMCID:PMC4307869","volume":"29","author":"M Dirani","year":"2014","unstructured":"Dirani M, Nasreddine W, Abdulla F, Beydoun A. Seizure control and improvement of neurological dysfunction in Lafora disease with perampanel. Epilepsy Behav Case Rep. 2014;29(2):164\u20136. https:\/\/doi.org\/10.1016\/j.ebcr.2014.09.003.PMID:25667898;PMCID:PMC4307869.","journal-title":"Epilepsy Behav Case Rep."},{"issue":"1","key":"3537_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13023-019-1132-3.PMID:31227012;PMCID:PMC6588886","volume":"14","author":"F Bisulli","year":"2019","unstructured":"Bisulli F, Muccioli L, d\u2019Orsi G, Canafoglia L, Freri E, Licchetta L, Mostacci B, Riguzzi P, Pondrelli F, Avolio C, Martino T, Michelucci R, Tinuper P. Treatment with metformin in twelve patients with Lafora disease. Orphanet J Rare Dis. 2019;14(1):149. https:\/\/doi.org\/10.1186\/s13023-019-1132-3.PMID:31227012;PMCID:PMC6588886.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"3537_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.5146\/tjpath.2021.01522","volume":"37","author":"E Kimilo\u011flu","year":"2021","unstructured":"Kimilo\u011flu E, Akba\u015f P, \u00d6re \u00d6E, Turan \u00c7. A case of Lafora disease diagnosed by axillary skin biopsy. Turk Patoloji Derg. 2021;37(3):264\u20135. https:\/\/doi.org\/10.5146\/tjpath.2021.01522.","journal-title":"Turk Patoloji Derg."},{"issue":"3\u20134","key":"3537_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/epi4.12009","volume":"1","author":"R Zutt","year":"2016","unstructured":"Zutt R, Drost G, Vos YJ, Elting JW, Miedema I, Tijssen MAJ, Brouwer OF, de Jong BM. Unusual course of Lafora disease. Epilepsia Open. 2016;1(3\u20134):136\u20139. https:\/\/doi.org\/10.1002\/epi4.12009.","journal-title":"Epilepsia Open"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03537-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-022-03537-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03537-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T10:11:02Z","timestamp":1701166262000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-022-03537-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3537"],"URL":"https:\/\/doi.org\/10.1186\/s13256-022-03537-x","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"assertion":[{"value":"27 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethic Committee of the University Clinical Center of Kosovo approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s legal guardian(s) for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no competing interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"360"}}